dihexa and cancer risk hgf c met Targeting the HGF/c-MET pathway in advanced pancreatic cancer dihexa stability ph degradation pathways

Funding: Supported by NIH grants P30 DK056341 (Washington University Nutrition and Obesity Research Center), P30 DK020579 (Washington University Diabetes Research Center), UL1 TR000448 (Washington University Institute of Clinical and Translational Sciences), and T32 DK007120, and the Barnes-Jewish Hospital Foundation

Interestingly, the mutations of P29 to positively charged residues (P29R and P29K mutations) increased the peptide binding for amylin receptor 1 ECD (Figure 4D)

The protocol for this study was pre-registered on the International Prospective Register of Systematic Reviews (PROSPERO), under the registration number: CRD420251161230

In the case of peptides, only a few traditional types find application due to biological instability and rapid breakdown